Compass Therapeutics to Participate in Upcoming November Investor Events
Rhea-AI Summary
Compass Therapeutics (Nasdaq: CMPX) will participate in three investor events in November 2025: Guggenheim Healthcare Innovation Conference in Boston on Nov 10, 2025 at 3:30 PM ET, Stifel 2025 Healthcare Conference in New York on Nov 12, 2025 at 4:00 PM ET, and Jefferies Global Healthcare Conference in London on Nov 20, 2025 at 12:00 PM GMT.
Each presentation will be webcast; links are provided and presentations will be archived for 90 days on Compass’ Events page for replay.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, CMPX declined NaN%, reflecting a moderate negative market reaction. Argus tracked a peak move of +2.3% during that session. Argus tracked a trough of -6.5% from its starting point during tracking. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of November.
Details are as follows:
Guggenheim 2nd Annual Healthcare Innovation Conference
Location: Boston, MA
Date: Monday, November 10, 2025
Time: 3:30 PM ET
Webcast Link: https://event.summitcast.com/view/6h3HS7z68WnTQE5PS7Vq8J/Whrfp7V7J4xxPSb6WEtmkp
Stifel 2025 Healthcare Conference
Location: New York, NY
Date: Wednesday, November 12, 2025
Time: 4:00 PM ET
Webcast Link: https://event.summitcast.com/view/cwkmPXkC4dosg6MoG95rxb/PK2LUcfo5tANjQo7JVHDsB
Jefferies Global Healthcare Conference
Location: London, UK
Date: Thursday, November 20, 2025
Time: 12:00 PM GMT
Webcast Link: https://wsw.com/webcast/jeff332/cmpx/1860808
Virtual/Replay availability: Presentations will be archived for 90 days on Compass’ Events page.
About Compass Therapeutics
Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company’s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. Compass has built a robust pipeline of novel product candidates designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. The company plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts.
Investor Contact
ir@compasstherapeutics.com
Media Contact
Anna Gifford, Chief of Staff
media@compasstherapeutics.com
617-500-8099
FAQ
When will Compass Therapeutics (CMPX) present at the Guggenheim Healthcare Innovation Conference?
How can investors watch Compass Therapeutics (CMPX) at the Stifel 2025 Healthcare Conference on November 12, 2025?
What is the date and time for Compass Therapeutics (CMPX) at the Jefferies Global Healthcare Conference in London?
Will Compass Therapeutics (CMPX) make replays of the November 2025 presentations available?
Where can I find the webcast links for Compass Therapeutics (CMPX) November 2025 events?
Are the Compass Therapeutics (CMPX) November 2025 investor events open to the public via webcast?
